Close Menu

NEW YORK – Exact Sciences said today that it has received approval from the US Food and Drug Administration to expand the indication for its Cologuard colorectal cancer test to average-risk individuals aged 45 and older.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.